Aprepitant and granisetron for the prophylaxis of radiotherapy-induced nausea and vomiting after moderately emetogenic radiotherapy for bone metastases: a prospective pilot study

PURPOSE: We evaluated the novel combination of aprepitant and granisetron for the prophylaxis of radiotherapy-induced nausea and vomiting (rinv) among patients receiving moderately-emetogenic radiotherapy for thoracolumbar bone metastases. METHODS: In this single-centre two-arm nonrandomized prospec...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Curr Oncol
Prif Awduron: Dennis, K., De Angelis, C., Jon, F., Lauzon, N., Pasetka, M., Holden, L., Barnes, E., Danjoux, C., Sahgal, A., Tsao, M., Chow, E.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Multimed Inc. 2014
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4257120/
https://ncbi.nlm.nih.gov/pubmed/25489264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.21.2051
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg